The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut-Reference-Cited by-同舟云学术

The prostaglandin receptor EP4 suppresses colitis, mucosal damage and CD4 cell activation in the gut

Published:2002-04-01 Issue:7 Volume:109 Page:883-893
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Kabashima Kenji,Saji Tomomi,Murata Takahiko,Nagamachi Miyako,Matsuoka Toshiyuki,Segi Eri,Tsuboi Kazuhito,Sugimoto Yukihiko,Kobayashi Takuya,Miyachi Yoshiki,Ichikawa Atsushi,Narumiya Shuh

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference44 articles.

1. Inflammatory bowel disease: Etiology and pathogenesis

2. Animal models of mucosal inflammation and their relation to human inflammatory bowel disease

3. Inflammatory bowel disease incidence: up, down or unchanged?

4. Side effects of nonsteroidal anti-inflammatory drugs on the small and large intestine in humans

5. Nonsteroidal Anti-Inflammatory Drugs Activate Quiescent Inflammatory Bowel Disease

Cited by 351 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uterine prostaglandin DP receptor induced upon implantation contributes to decidualization together with EP4 receptor;Journal of Lipid Research;2024-08

2. Ileal Crohn’s Disease Exhibits Reduced Activity of Phospholipase C-β3-Dependent Wnt/β-Catenin Signaling Pathway;Cells;2024-06-05

3. PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function;Nature;2024-04-24

4. Revisiting prostaglandin E2: A promising therapeutic target for osteoarthritis;Clinical Immunology;2024-03

5. Prostaglandin E2 and myocarditis; friend or foe?;Biochemical Pharmacology;2023-11